0

COLY-MYCIN M از شرکت PAR STERILE PRODUCTS

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COLY-MYCIN M از شرکت PAR STERILE PRODUCTS

New Drug Application (NDA): 050108

Company: PAR STERILE PRODUCTS

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COLY-MYCIN M COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription

AP

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/04/1970 ORIG-1 Approval

UNKNOWN

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/14/2017 SUPPL-33 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050108s033lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/050108Orig1s033ltr.pdf

03/07/2013 SUPPL-30 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050108s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/050108Orig1s030ltr.pdf

05/13/2009 SUPPL-26 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050108s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/050108s026ltr.pdf

01/12/2006 SUPPL-24 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050108s024lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050108s024ltr.pdf

12/20/2002 SUPPL-23 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50108slr023ltr.pdf

09/28/2001 SUPPL-22 Manufacturing (CMC)-Control

Label is not available on this site.

11/26/1999 SUPPL-21 Labeling

Label is not available on this site.

04/28/1994 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

10/23/1981 SUPPL-19 Manufacturing (CMC)-Control

Label is not available on this site.

08/18/1980 SUPPL-18 Labeling

Label is not available on this site.

01/18/1980 SUPPL-17 Manufacturing (CMC)-Expiration Date

Label is not available on this site.

08/31/1979 SUPPL-16 Labeling

Label is not available on this site.

12/08/1978 SUPPL-15 Manufacturing (CMC)-Control

Label is not available on this site.

05/17/1976 SUPPL-14 Manufacturing (CMC)-Control

Label is not available on this site.

09/11/1975 SUPPL-13 Manufacturing (CMC)-Control

Label is not available on this site.

12/14/1973 SUPPL-12 Manufacturing (CMC)-Control

Label is not available on this site.

06/05/1972 SUPPL-9 Manufacturing (CMC)-Control

Label is not available on this site.

02/11/1971 SUPPL-8 Labeling

Label is not available on this site.

12/19/1970 SUPPL-7 Labeling

Label is not available on this site.

12/22/1970 SUPPL-6 Manufacturing (CMC)-Control

Label is not available on this site.

08/17/1970 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

12/10/1985 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

04/11/1983 SUPPL-3 Manufacturing (CMC)-Expiration Date

Label is not available on this site.

03/14/1983 SUPPL-2 Manufacturing (CMC)-Expiration Date

Label is not available on this site.

10/07/1982 SUPPL-1 Labeling

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
04/14/2017 SUPPL-33

Labeling-Package Insert

Label (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050108s033lbl.pdf
03/07/2013 SUPPL-30

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050108s030lbl.pdf
05/13/2009 SUPPL-26

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050108s026lbl.pdf
01/12/2006 SUPPL-24

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050108s024lbl.pdf

COLY-MYCIN M

INJECTABLE;INJECTION; EQ 150MG BASE/VIAL

TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065364 FRESENIUS KABI USA
COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065177 NEXUS PHARMS
COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription No AP 201365 SAGENT PHARMS INC
COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription No AP 205356 XELLIA PHARMS APS
COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription No AP 064216 XGEN PHARMS
COLY-MYCIN M COLISTIMETHATE SODIUM EQ 150MG BASE/VIAL INJECTABLE;INJECTION Prescription Yes AP 050108 PAR STERILE PRODUCTS
بخوانید  ABILIFY از شرکت OTSUKA
برچسب‌ها:

نظرات کاربران